CREB5 Promotes Resistance to Androgen-Receptor Antagonists and Androgen Deprivation in Prostate Cancer
Justin H. Hwang(University of Minnesota), William C. Hahn(Broad Institute), Michael L. Beshiri(National Cancer Institute), Ginevra Botta(Broad Institute), Eliezer M. Van Allen(Dana-Farber Cancer Institute), Adam G. Sowalsky(National Cancer Institute), Xintao Qiu(Dana-Farber Cancer Institute), Gabriel J. Sandoval(Broad Institute), Jonathan So(Broad Institute), Stephanie A. Wankowicz(Vanderbilt University), Hubert Pakula(Cornell University), Camden Richter(Dana-Farber Cancer Institute), G. Celine Han(Broad Institute), Kathleen Kelly(National Cancer Institute), Andrew O. Giacomelli(Humber Polytechnic), Ole Gjoerup(Foundation Medicine (United States)), Seav Huong Ly(Broad Institute), Henry W. Long(Dana-Farber Cancer Institute), Lior Golumb(Broad Institute), Andrew L. Hong(Emory Healthcare), Massimo Loda(Cornell University), Atish D. Choudhury(Dana-Farber Cancer Institute), Leigh Ellis(Prostate Cancer Research), Chao Dai(Broad Institute), David E. Root(Broad Institute), Matthew L. Freedman(Brigham and Women's Hospital), Ji Li(Sichuan University), Anjali V. Sheahan(Broad Institute), David Liu(University of Louisville), Federica Piccioni(Broad Institute), Ji-Heui Seo(Dana-Farber Cancer Institute), Alexander T. M. Cheung(Broad Institute)
Cited by 80
Related Papers
Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq
|Science|2016|5.3k
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
|Nature|2009|4.2k
Integrative Clinical Genomics of Advanced Prostate Cancer
|Cell|2015|3.6k